Levity Weight Loss Review 2026: Pricing, Medications & How Trimi Compares

What is Levity?

Most low-cost GLP-1 telehealth platforms are built around compounded medication. Levity leads with the opposite: FDA-approved brand-name pens, in stock, at one bundled monthly price that includes the consultation, the prescription, the medication itself, shipping in discreet refrigerated packaging, follow-up appointments, and what Levity describes as unlimited clinical support.

One number needs a caveat up front. Levity's homepage advertises a first month from $129 (code WELCOME) and “from $179/mo thereafter” — yet every treatment its product pages document is a brand pen priced between $1,199 and $1,599 a month, and the compounded semaglutide page that would explain a sub-$200 tier returned a page-not-found when we checked. If that entry price is what brings you in, ask Levity exactly which treatment it buys before you start the consultation.

The operational details Levity publishes are reassuring for a category with plenty of bad actors: it names its Head of Pharmacy and a board-certified physician with license and NPI numbers, states its LegitScript certification, requires an online consultation (with photo ID) before any prescription, and posts an unusually complete side-effect disclosure — including the class's boxed warning — on its own FAQ page. Support runs Monday through Friday, 9am–5pm EST.

What Levity is not, as of August 2026, is a nationwide or a budget option. Its FAQ lists 35 states, and every price its product pages document sits above $1,000 a month. How you weigh that depends entirely on whether you specifically want the brand-name pen — the question this review keeps coming back to.

Levity pricing in 2026: every published number

These are the prices on Levity's public pages as of August 2026, next to Trimi's annual-plan pricing. Levity applies a $50 first-month discount with code WELCOME; the ongoing price is the number that matters for a long-term medication.

Two notes keep this table honest. First, brand-name and compounded prices are not an apples-to-apples comparison: brand prices reflect the cost of the FDA-approved products themselves, while compounded preparations are prepared per individual prescription by a state-licensed pharmacy and are not FDA-approved as drugs. The like-for-like comparison for Trimi's rows is compounded-to-compounded — and Levity's live product pages do not currently document a compounded option to put beside them.

Second, “from” pricing deserves a follow-up question. GLP-1 doses typically increase over the first several months of treatment, and Levity prices its brand pens by dosage — each product page lists its monthly figure as a “from” price with a pricing-by-dosage view. The homepage's “from $179/mo” entry price, meanwhile, carries no documented treatment at all. Before you enroll anywhere, ask what the price is at your maintenance dose. Our compounded semaglutide cost guide breaks down the four billing models behind numbers like these.

What Levity does well

A fair review starts with the parts of Levity's model that genuinely work in patients' favor. Everything below comes from Levity's own published pages, verified August 2026.

Where Levity is limited

None of these are disqualifying — they are structural trade-offs of a brand-first, month-to-month model.

Levity vs flat all-in pricing: the model question

Levity and Trimi actually agree on the most patient-friendly idea in this market: one published price that covers everything, with no membership fee stacked on top. Plenty of platforms do it differently — our Mochi Health review walks through a membership-plus-medication model where the advertised medication price and the real monthly total are two different numbers.

Where the two models split is what sits inside the bundle and how the commitment works. Levity's bundle is built around brand-name pens billed month-to-month: maximum flexibility, at $1,199–$1,599 a month. Trimi's model (the company was founded in May 2024 and is headquartered in New York City) is built around compounded medication on an annual plan: $99/month for compounded semaglutide or $125/month for compounded tirzepatide, the same price at every prescribed dose, with free next-day-air shipping — once prescribed, medication typically arrives within 36 hours. The honest trade-off is the 12-month commitment, which Trimi backs with a 6-month money-back promise rather than a cancel-anytime structure.

Dose economics matter more than most people expect. Because GLP-1 doses typically titrate upward over the first months, a “from” price at the starting dose can understate the cost of the months that make up most of your treatment — which is why Levity's pricing-by-dosage view is worth opening before you enroll, and why flat-at-every-dose pricing removes the variable entirely. The same logic applies to supply cadence — our 3-month supply guide covers why quarterly shipments are the practical ceiling for compounded vials.

And if you are already on treatment elsewhere, switching does not mean starting over: dose progress transfers with your medical records, as our guide to switching GLP-1 providers explains.

What results can you realistically expect?

The efficacy evidence in this category comes from clinical trials of the FDA-approved products. According to the STEP 1 trial published in the New England Journal of Medicine (2021), semaglutide 2.4 mg produced a 14.9% average body-weight reduction over 68 weeks alongside diet and exercise changes. In the SURMOUNT-1 trial (New England Journal of Medicine, 2022), tirzepatide at the highest dose produced up to a 20.9% average reduction over 72 weeks. Levity's own product pages quote similar “up to” figures for its brand pens.

Two caveats apply to every provider in this review. First, those are population averages from trials of the FDA-approved medications — compounded preparations have not been studied in clinical trials of their own, and individual results vary with baseline weight, adherence, diet, activity, and genetics. Second, the medication is the main driver of outcomes, which means the clinical program around it — licensed provider oversight, sensible titration, side-effect management — matters more than app polish or brand packaging. Per FDA guidance on drug compounding, compounded drugs are not reviewed by the agency for safety, effectiveness, or quality before marketing, which is why pharmacy licensing and provider oversight are the things worth verifying at any compounded program. Cost details for the tirzepatide route are in our compounded tirzepatide cost guide.

Who Levity fits — and who it doesn't

Frequently asked questions

Verdict: a well-run program for a specific buyer

Levity is one of the more transparent operations in GLP-1 telehealth. Its pricing is genuinely all-in, its compliance signals are published rather than implied, and its cancel-anytime structure asks for no commitment it hasn't earned. For the patient who has decided they want a brand-name pen and can absorb a four-figure monthly bill, it is a credible way to get one with real clinical support around it.

For everyone else, the math is harder to even run. Most people comparing telehealth GLP-1 programs are looking for the compounded route — and as of our check, Levity's live product pages do not document one. The homepage advertises “from $179/mo,” but the treatments its pages document start at $1,199. If the compounded route is your plan, compare compounded-to-compounded, confirm any provider's price at your maintenance dose, and read our full compounded semaglutide cost breakdown before you pay anyone.